Lv2
196 积分 2025-03-25 加入
Engineering IL-2 for immunotherapy of autoimmunity and cancer
2个月前
已完结
Sialylated CD43 forms a glyco-immune barrier that restrains antileukemic immunity
5个月前
已完结
Treatment of NSCLC after chemoimmunotherapy — are we making headway?
6个月前
已完结
Development of Globo-H conjugated bacteriophage Qβ mutant virus-like particles as an anticancer vaccine
6个月前
已完结
Wnt signaling dynamics in head and neck squamous cell cancer tumor-stroma interactions
6个月前
已完结
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
7个月前
已完结
One stone two birds: Introducing piperazine into a series of nucleoside derivatives as potent and selective PRMT5 inhibitors
7个月前
已完结
Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with MTAP Deletion
7个月前
已完结
Artificial intelligence in drug development
8个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
8个月前
已完结
皖公网安备34019202002308
